Atlas Trials

ICG-fluorescence Imaging for Intraoperative Breast Cancer Margins Evaluation: a Dose-timing Study

Clinical trial NCT06227338 · RECRUITING

Trial details

NCT number
NCT06227338
Sponsor
Jules Bordet Institute
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Breast Cancer
Start date
2024-02-12
Primary completion
2026-01-01
Enrollment
250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.